New president and CEO at Lux Biosciences
This article was originally published in Scrip
Lux Biosciences (US) has named Dean Mitchell president and chief executive officer. He is the former president, CEO and director of Alpharma. Before joining Alpharma, Mr Mitchell was president and CEO of Guilford Pharmaceuticals, which was acquired by MGI Pharmaceuticals in 2005.